Detalles de la búsqueda
1.
The COMPARE head-to-head, randomized controlled trial of SEL-212 (pegadricase plus rapamycin-containing nanoparticle, ImmTOR™) versus pegloticase for refractory gout.
Rheumatology (Oxford)
; 63(4): 1058-1067, 2024 Apr 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-37449908
2.
Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis.
Rheumatology (Oxford)
; 62(10): 3268-3279, 2023 10 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36727470
3.
Safety and efficacy of filgotinib for Japanese patients with RA and inadequate response to MTX: FINCH 1 52-week results and FINCH 4 48-week results.
Mod Rheumatol
; 33(4): 668-679, 2023 Jul 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-35920102
4.
Efficacy and safety of selective TYK2 inhibitor, deucravacitinib, in a phase II trial in psoriatic arthritis.
Ann Rheum Dis
; 81(6): 815-822, 2022 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35241426
5.
Apremilast monotherapy for long-term treatment of active psoriatic arthritis in DMARD-naïve patients.
Rheumatology (Oxford)
; 61(3): 1035-1043, 2022 03 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34100922
6.
Efficacy and safety of filgotinib in combination with methotrexate in Japanese patients with active rheumatoid arthritis who have an inadequate response to methotrexate: Subpopulation analyses of 24-week data of a global phase 3 study (FINCH 1).
Mod Rheumatol
; 32(2): 263-272, 2022 Feb 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-34910188
7.
Efficacy and safety of fasinumab in patients with chronic low back pain: a phase II/III randomised clinical trial.
Ann Rheum Dis
; 80(4): 509-517, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33199274
8.
Long-term safety of sarilumab in rheumatoid arthritis: an integrated analysis with up to 7 years' follow-up.
Rheumatology (Oxford)
; 59(2): 292-302, 2020 02 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31312844
9.
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial.
Lancet
; 390(10093): 457-468, 2017 07 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-28629665
10.
Apremilast monotherapy in DMARD-naive psoriatic arthritis patients: results of the randomized, placebo-controlled PALACE 4 trial.
Rheumatology (Oxford)
; 57(7): 1253-1263, 2018 Jul 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29635379
11.
Long-term effects of interleukin-17A inhibition with secukinumab in active ankylosing spondylitis: 3-year efficacy and safety results from an extension of the Phase 3 MEASURE 1 trial.
Clin Exp Rheumatol
; 36(1): 50-55, 2018.
Artículo
en Inglés
| MEDLINE | ID: mdl-28516874
12.
Blood-Borne RNA Correlates with Disease Activity and IFN-Stimulated Gene Expression in Systemic Lupus Erythematosus.
J Immunol
; 197(7): 2854-63, 2016 10 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-27534558
13.
Sustained efficacy, safety and patient-reported outcomes of certolizumab pegol in axial spondyloarthritis: 4-year outcomes from RAPID-axSpA.
Rheumatology (Oxford)
; 56(9): 1498-1509, 2017 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-28498975
14.
Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial.
BMC Musculoskelet Disord
; 17: 331, 2016 08 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-27502582
15.
Efficacy and safety of ascending methotrexate dose in combination with adalimumab: the randomised CONCERTO trial.
Ann Rheum Dis
; 74(6): 1037-44, 2015 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-24550168
16.
Efficacy and Safety of Secukinumab in US Patients with Psoriatic Arthritis: A Subgroup Analysis of the Phase 3 FUTURE Studies.
Rheumatol Ther
; 11(3): 675-689, 2024 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-38625671
17.
Efficacy and Safety of Filgotinib in Patients with High Risk of Poor Prognosis Who Showed Inadequate Response to MTX: A Post Hoc Analysis of the FINCH 1 Study.
Rheumatol Ther
; 10(1): 53-70, 2023 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-36209441
18.
Double-blind randomized trials of single-tablet ibuprofen/high-dose famotidine vs. ibuprofen alone for reduction of gastric and duodenal ulcers.
Am J Gastroenterol
; 107(3): 379-86, 2012 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-22186979
19.
Abatacept in the treatment of patients with psoriatic arthritis: results of a six-month, multicenter, randomized, double-blind, placebo-controlled, phase II trial.
Arthritis Rheum
; 63(4): 939-48, 2011 Apr.
Artículo
en Inglés
| MEDLINE | ID: mdl-21128258
20.
Efficacy and safety of tofacitinib by background methotrexate dose in psoriatic arthritis: post hoc exploratory analysis from two phase III trials.
Clin Rheumatol
; 41(2): 499-511, 2022 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-34510295